In addition to the Wnt/β-catenin signaling pathway, we demonstrated that KLF10 contributed to the cancer stemness phenotype by transcriptionally regulating Notch-3 and Notch-4 and competing with E74-like ETS transcription factor 3 (ELF3) for promoter binding. The gene discussed is NOTCH3; the disease is cancer.